Braman SS. The global burden of asthma. Chest. 2006;130:4S–12S.

Article  PubMed  Google Scholar 

Dharmage SC, Perret JL, Custovic A. Epidemiology of asthma in children and adults. Front Pediatr. 2019;7:246.

The Global Asthma Report 2022. Int J Tuberc Lung Dis. 2022 26:1–104.

Fahy JV. Type 2 inflammation in asthma-present in most, absent in many. Nat Rev Immunol. 2015;15:57–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spellberg B, Edwards JE. Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis. 2001;32:76–102.

Article  CAS  PubMed  Google Scholar 

Song D, Cahn D, Duncan GA. Mucin biopolymers and their barrier function at airway surfaces. Langmuir. 2020;36:12773–83.

Article  CAS  PubMed  Google Scholar 

Patel VH, Thannir S, Dhanani M, Augustine I, Sandeep SL, Mehadi A, et al. Current limitations and recent advances in the management of asthma. Dis Mon. 2023;69:101483.

Article  PubMed  Google Scholar 

Ip M, Lam K, Yam L, Kung A, Ng M. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest. 1994;105:1722–7.

Article  CAS  PubMed  Google Scholar 

Gaga M, Zervas E. Oral steroids in asthma: a double-edged sword. Eur Respir J. 2019;54:1902034.

Article  PubMed  Google Scholar 

Boboltz A, Kumar S, Duncan GA. Inhaled drug delivery for the targeted treatment of asthma. Adv Drug Deliv Rev. 2023;198:114858.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zavorotinskaya T, Tomkinson A, Murphy JE. Treatment of experimental asthma by long-term gene therapy directed against IL-4 and IL-13. Mol Ther. 2003;7:155–62.

Article  CAS  PubMed  Google Scholar 

Behera AK, Kumar M, Lockey RF, Mohapatra SS. Adenovirus-mediated interferon γ gene therapy for allergic asthma: involvement of interleukin 12 and STAT4 signaling. Hum Gene Ther. 2002;13:1697–709.

Article  CAS  PubMed  Google Scholar 

Xie Y, Kim NH, Nadithe V, Schalk D, Thakur A, Kılıç A, et al. Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma. J Controlled Rel. 2016;229:120–9.

Article  CAS  Google Scholar 

Choi M, Gu J, Lee M, Rhim T. A new combination therapy for asthma using dual-function dexamethasone-conjugated polyethylenimine and vitamin D binding protein siRNA. Gene Ther. 2017;24:727–34.

Article  CAS  PubMed  Google Scholar 

Thanki K, Blum KG, Thakur A, Rose F, Foged C. Formulation of RNA interference-based drugs for pulmonary delivery: challenges and opportunities. Therapeutic Deliv. 2018;9:731–49.

Article  CAS  Google Scholar 

Tanaka M, Nyce JW. Respirable antisense oligonucleotides: a new drug class for respiratory disease. Respir Res. 2001;2:5–9.

CAS  PubMed  Google Scholar 

Chiang PC, Chen JC, Chen LC, Kuo ML. Adeno-associated virus-mediated interleukin-12 gene expression alleviates lung inflammation and type 2 T-helper-responses in ovalbumin-sensitized asthmatic mice. Hum Gene Ther. 2022;33:1052–61.

Article  CAS  PubMed  Google Scholar 

Dunican EM, Watchorn DC, Fahy JV. Autopsy and imaging studies of mucus in asthma. lessons learned about disease mechanisms and the role of mucus in airflow obstruction. Ann Am Thorac Soc. 2018;15:S184–91.

Article  PubMed  PubMed Central  Google Scholar 

Dunnill MS. The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol. 1960;13:27–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huber HL, Koessler KK. The pathology of bronchial asthma. Arch Intern Med. 1922;30:689–760.

Lachowicz-Scroggins ME, Yuan S, Kerr SC, Dunican EM, Yu M, Carrington SD, et al. Abnormalities in MUC5AC and MUC5B protein in airway mucus in asthma. Am J Respir Crit Care Med. 2016;194:1296–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song D, Iverson E, Kaler L, Bader S, Scull MA, Duncan GA. Modeling airway dysfunction in asthma using synthetic mucus biomaterials. ACS Biomater Sci Eng. 2021;7:2723–33.

Bonser LR, Zlock L, Finkbeiner W, Erle DJ. Epithelial tethering of MUC5AC-rich mucus impairs mucociliary transport in asthma. J Clin Investig. 2016;126:2367–71.

Article  PubMed  PubMed Central  Google Scholar 

Siddiqui S, Johansson K, Joo A, Bonser LR, Koh KD, Le Tonqueze O, et al. Epithelial miR-141 regulates IL-13–induced airway mucus production. JCI Insight. 2021;6:e139019.

Article  PubMed  PubMed Central  Google Scholar 

Wang JH, Gessler DJ, Zhan W, Gallagher TL, Gao G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Sig Transduct Target Ther. 2024;9:1–33.

Google Scholar 

Liu D, Li T, Liu L, Che X, Li X, Liu C, et al. Adeno-associated virus therapies: pioneering solutions for human genetic diseases. Cytokine Growth Factor Rev. 2024;80:109–20.

Article  CAS  PubMed  Google Scholar 

Halbert CL, Allen JM, Miller AD. Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J Virol. 2001;75:6615–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li W, Zhang L, Wu Z, Pickles RJ, Samulski RJ. AAV-6 mediated efficient transduction of mouse lower airways. Virology. 2011;417:327–33.

Article  CAS  PubMed  Google Scholar 

Duncan GA, Kim N, Colon-Cortes Y, Rodriguez J, Mazur M, Birket SE, et al. An adeno-associated viral vector capable of penetrating the mucus barrier to inhaled gene therapy. Mol Ther Methods Clin Dev. 2018;9:296–304.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Limberis MP, Vandenberghe LH, Zhang L, Pickles RJ, Wilson JM. Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro. Mol Ther. 2009;17:294–301.

Article  CAS  PubMed  Google Scholar 

Kurosaki F, Uchibori R, Mato N, Sehara Y, Saga Y, Urabe M, et al. Optimization of adeno-associated virus vector-mediated gene transfer to the respiratory tract. Gene Ther. 2017;24:290–7.

Article  CAS  PubMed  Google Scholar 

Walkey CJ, Snow KJ, Bultcha J, Cox AR, Martinez AE, Ljungberg MC, et al. A comprehensive atlas of AAV tropism in the mouse. Mol Ther. 2025;33:1282–99.

Turner J, Roger J, Fitau J, Combe D, Giddings J, Heeke GV, et al. Goblet cells are derived from a FOXJ1-expressing progenitor in a human airway epithelium. Am J Respir Cell Mol Biol. 2011;44:276–84.

Article  CAS  PubMed  Google Scholar 

Laoukili J, Perret E, Willems T, Minty A, Parthoens E, Houcine O, et al. IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells. J Clin Invest. 2001;108:1817–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koh KD, Siddiqui S, Cheng D, Bonser LR, Sun DI, Zlock LT, et al. Efficient RNP-directed human gene targeting reveals SPDEF is required for IL-13-induced mucostasis. Am J Respir Cell Mol Biol. 2020;62:373–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song D, Iverson E, Kaler L, Boboltz A, Scull MA, Duncan GA. MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. Sci Adv. 2022;8:eabq5049.

Article  CAS